drugset / Trial / NCT02315872
ACTH for Fatigue in Multiple Sclerosis Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a study of Acthar gel (ACTH) in patients with relapsing multiple sclerosis who are experiencing chronic fatigue.
Timeline
- Start
- 2015-05-22
- Primary completion
- 2017-06-20
- Completion
- 2018-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACTH | Unknown | 40 iu | Subcutaneous |
| Subject | ACTH | Unknown | 80 iu | Subcutaneous |